Erythropoietin through the Placenta Barrier and Fetal Blood-Brain Barrier with Transient Uteroplacental Ischemia

MA Yu-shan, ZHOU Jun, LIU Hui, DU Yu, LIN Xue-mei

Abstract

To observe the permeability of recombinant human erythropoietin through placenta barrier and fetal blood-brain barrier after transient uteroplacental ischemia. Methods Rats on days 19 of pregnancy were divided into rhEPO treated group, ischemia-reperfusion group and sham-operated group. Fetal ischemia in rhEPO treated group and ischemia-reperfusion group was induced by bilateral occlusion of the utero-ovarian artery for 20 minutes. Different dosage of 125I-rhEPO (2500 U/kg,5000 U/kg,7500 U/kg) was injected into the rats through caudal veins 30 min before injury in rhEPO treated group and sham-operated group. Saline was administered intravenously 30 min before the induction of hypoxic-ischemic injury in ischemia-reperfusion group. The amniotic fluid, placenta and fetal organs including brain, liver, heart, lung and kidney were collected to measure the radioactivity at 24h after injury. Results 125I-rhEPO was detected in amniotic fluid, placenta and fetal organs. The radioactivity of 125I-rhEPO in these tissues increased gradually with the increased dose injected in rhEPO treated group and sham-operated group. There were significant differences in the radioactivity of 125I-rhEPO between rhEPO treated group and sham-operated group (P<0.05). Conclusion The permeability of rhEPO through placental barrier and blood-brain barrier increased under the condition of fetal ischemia and hypoxia.

 

Keywords: Recombinant human erythropoietin, Hypoxia-ischemia, Placental barrier, Blood brain barrier, Permeability

 

Full Text:

PDF


References


Baker PN. Johnson IR. Harvey PR. el al. A three-year follow-up children imaged in utero with echo-planar magnetic resonance. Am J Obstet Gynecol» 1994; 170( 1 Pt 1):32-33.

De Wilde JP. Rivers AW. Price DL, el al. A review of the current use of magnetic resonance imaging in pregnancy and

safety implications for the fetus. Prog Biophys Mol Biol.2005; 87(2-3):335-353.

Magin RL. Lee JK, Klintsova A, et al. Biological effect of long-duration high-field (4T) MRI on growth and development in the mouse. J Magn Reson Imaging,2000; 12(1): 140-149.

Vadeyar SH, Moore RJ, Strachan BK. et al. Effect of fetal magnetic resonance imaging on fetal heart rate patterns. Am J Obstet Gynecol,2000; 182(3) :666-669.

Mevissen M, Buntenkotter S, Loscher W. Effect of static and time 4'arying magnetic field on reproduction and fetal development in rats. Teratology,1994 ;50(3): 229-237.

Tamara TC, Jodi SD, Richard CA, et al. Central nervous system findings on fetal magnetic resonance imaging and outcomes in children with spina bifida. Obstet Gynecol. 2010; 116(2 Pt 1):323-329.

Gupta P, Sharma R, Kumar S, et al. Role of MRI in fetal abdominal cystic masses detected on prenatal sonography. Arch Gynecol Obstet, 2010; 281 (3): 519-526.

Hosny IA, Elghawabi HS. Ultrafast MRI of the fetus; an increasingly important tool in prenatal diagnosis of congenital anomalies. Magn Reso Imaging,2010;28(10); 1431-1439.

Huisman ТА. Martin E. Kubik-Huch R, etal. Fetal magnetic resonance imaging of the brain: technical considerations and normal brain development. Eur Radiol, 2002; 12 (8); 1941- 1951.

Huisman ТА, Wisser J, Martin E. el al. Fetal magnetic resonance imaging of the central nervous system: a pictorial essay. Eur Radiol,2002; 12(8): 1952-1961.


Refbacks

  • There are currently no refbacks.